These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11196530)

  • 1. Disappointing longterm result with disease modifying antirheumatic drugs.
    Marubini E
    J Rheumatol; 2001 Jan; 28(1):215. PubMed ID: 11196530
    [No Abstract]   [Full Text] [Related]  

  • 2. Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis.
    Hoekstra M; van de Laar MA; Bernelot Moens HJ; Kruijsen MW; Haagsma CJ
    J Rheumatol; 2003 Nov; 30(11):2325-9. PubMed ID: 14677172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease modifying antirheumatic drugs: longterm safety issues.
    Capell HA
    J Rheumatol Suppl; 2001 Jun; 62():10-5. PubMed ID: 11409152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medical treatment in rheumatoid arthritis and mortality].
    Isomäki H; Myllykangas-Luosujärvi R; Aho K
    Duodecim; 1995; 111(13):1185-6. PubMed ID: 9221224
    [No Abstract]   [Full Text] [Related]  

  • 5. Disease-modifying drugs in rheumatoid arthritis.
    Rahman A; Ahmed S; Underwood M
    Practitioner; 2001 Dec; 245(1629):1018-25. PubMed ID: 11771221
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of rheumatoid arthritis.
    Handa R
    Natl Med J India; 2004; 17(3):143-51. PubMed ID: 15253402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease modifying antirheumatic drugs in early rheumatoid arthritis: a longterm observational study.
    Papadopoulos NG; Alamanos Y; Papadopoulos IA; Tsifetaki N; Voulgari PV; Drosos AA
    J Rheumatol; 2002 Feb; 29(2):261-6. PubMed ID: 11838843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longterm maintenance therapy with disease modifying antirheumatic drugs.
    Capell H
    J Rheumatol Suppl; 2002 Nov; 66():38-43. PubMed ID: 12435167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the outcome of rheumatoid arthritis changed with the use of new disease-modifying antirheumatic drugs?
    Kremer J
    Arthritis Rheum; 2005 Oct; 53(5):636-8. PubMed ID: 16208649
    [No Abstract]   [Full Text] [Related]  

  • 10. Defining response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Hider SL; Bruce IN; Silman AJ; Symmons DP
    J Rheumatol; 2005 Jan; 32(1):6-10. PubMed ID: 15630715
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination treatment strategies in early rheumatoid arthritis.
    Suresh E; Lambert CM
    Ann Rheum Dis; 2005 Sep; 64(9):1252-6. PubMed ID: 15860511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure.
    Kapral T; Stamm T; Machold KP; Montag K; Smolen JS; Aletaha D
    Arthritis Res Ther; 2006; 8(2):R46. PubMed ID: 16507172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Attaching importance to the traditional disease modifying antirheumatic drugs].
    Yang XY
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1873-4. PubMed ID: 19039995
    [No Abstract]   [Full Text] [Related]  

  • 14. Rheumatoid arthritis.
    Lorenzo M
    Foot Ankle Clin; 2007 Sep; 12(3):525-37, vii. PubMed ID: 17765843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are biologics more effective than classical disease-modifying antirheumatic drugs?
    Nurmohamed MT; Dijkmans BA
    Arthritis Res Ther; 2008; 10(5):118. PubMed ID: 18828888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid disease.
    Subhash C; Agarwal AK; Rewari BB; Sangla KS; Vijay A
    J Assoc Physicians India; 1995 Mar; 43(3):232-3. PubMed ID: 11256928
    [No Abstract]   [Full Text] [Related]  

  • 17. The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets the road.
    Bathon JM; Cohen SB
    Arthritis Rheum; 2008 Jun; 59(6):757-9. PubMed ID: 18512712
    [No Abstract]   [Full Text] [Related]  

  • 18. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
    Nikolaisen C; Rekvig OP; Nossent HC
    Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-modifying antirheumatic drugs.
    Brasington R
    J Hand Surg Am; 2009 Feb; 34(2):347-8. PubMed ID: 19181237
    [No Abstract]   [Full Text] [Related]  

  • 20. Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Comment on the article by Saag et al.
    van Tuyl LH; Lems WF; Voskuyl AE; Dijkmans BA; Boers M; Kerstens PJ
    Arthritis Rheum; 2009 Jan; 61(1):141-2; author reply 141-2. PubMed ID: 19116962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.